These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6635442)

  • 1. In vitro study of the combination of rifampin with oxacillin against Staphylococcus aureus.
    Van der Auwera P; Klastersky J
    Rev Infect Dis; 1983; 5 Suppl 3():S509-14. PubMed ID: 6635442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus.
    Maduri Traczewski M; Goldmann DA; Murphy P
    Antimicrob Agents Chemother; 1983 Apr; 23(4):571-6. PubMed ID: 6859835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of novobiocin and rifampin alone and in combination against oxacillin-resistant Staphylococcus aureus.
    Johnston BL; Kwok RY; Mulligan ME
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):137-47. PubMed ID: 3440369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
    Ho JL; Klempner MS
    Diagn Microbiol Infect Dis; 1986 Feb; 4(2):133-8. PubMed ID: 3956136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Killing rate and serum bactericidal activity of oxacillin, rifampin and ciprofloxacin against Staphylococcus aureus.
    Moretti MV; Fiorio M; Pasticci MB; Moretti A; Baldelli F; Pauluzzi S
    Microbiologica; 1989 Oct; 12(4):297-306. PubMed ID: 2586332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rifampin and oxacillin on the ultrastructure and growth of Staphylococcus aureus.
    Lorian V; Atkinson B; Kim Y
    Rev Infect Dis; 1983; 5 Suppl 3():S418-27. PubMed ID: 6556709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
    Drugeon HB; Caillon J; Juvin ME
    J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism between nafcillin or oxacillin and rifampin against Staphylococcus aureus.
    Watanakunakorn C; Tisone JC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):920-2. PubMed ID: 7181497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unpredictable effects of rifampin as an adjunctive agent in elimination of rifampin-susceptible and -resistant Staphylococcus aureus strains grown in biofilms.
    Croes S; Beisser PS; Neef C; Bruggeman CA; Stobberingh EE
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3907-12. PubMed ID: 20606067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
    Rand KH; Houck HJ
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activities of daptomycin, vancomycin, and oxacillin in human monocytes and of daptomycin in combination with gentamicin and/or rifampin in human monocytes and in broth against Staphylococcus aureus.
    Baltch AL; Ritz WJ; Bopp LH; Michelsen PB; Smith RP
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1559-62. PubMed ID: 17283190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The synergistic effect of PDT and oxacillin on clinical isolates of Staphylococcus aureus.
    Iluz N; Maor Y; Keller N; Malik Z
    Lasers Surg Med; 2018 Jul; 50(5):535-551. PubMed ID: 29333608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antistaphylococcal activity of rifampin with other antibiotics.
    Zinner SH; Lagast H; Klastersky J
    J Infect Dis; 1981 Oct; 144(4):365-71. PubMed ID: 6270215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of rapid agglutination methods to detect oxacillin-resistant Staphylococcus aureus.
    Ruane PJ; Morgan MA; Citron DM; Mulligan ME
    J Clin Microbiol; 1986 Sep; 24(3):490-2. PubMed ID: 3489732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Antistaphylococcal Synergistic Effect of Isoflavone Metabolite Demethyltexasin with Amoxicillin and Oxacillin.
    Rondevaldova J; Hummelova J; Tauchen J; Kokoska L
    Microb Drug Resist; 2018; 24(1):24-29. PubMed ID: 28570834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility of Staphylococcus aureus isolated from blood to currently used antistaphylococcal drugs.
    Baiocchi P; Galiè M; Santini C; Carfagna P; Cassone M; Tarasi D; Venditti M
    J Chemother; 1998 Feb; 10(1):25-8. PubMed ID: 9531072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combination of oxacillin and non-beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus.
    Komatsuzawa H; Suzuki J; Sugai M; Miyake Y; Suginaka H
    J Antimicrob Chemother; 1994 Jun; 33(6):1155-63. PubMed ID: 7928809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of fosfomycin combined with rifampin, pefloxacin and imipenem against staphylococci: a study by the time-kill curve method.
    Quentin C; Saivin S; Lafferriere C; Noury P; Bebear C
    Drugs Exp Clin Res; 1987; 13(4):219-24. PubMed ID: 3476291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the in vitro antistaphylococcal effect of oxacillin and tetracycline by the anti-inflammatory drug diacetyl rhein.
    Nguon S; Novy P; Kokoska L
    Chemotherapy; 2013; 59(6):447-52. PubMed ID: 25138175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of vancomycin-beta-lactam combinations against heterogeneously vancomycin-resistant Staphylococcus aureus (hetero-VRSA).
    Kim YS; Kiem S; Yun HJ; Jung SI; Oh WS; Kim SW; Peck KR; Lee NY; Song JH
    J Korean Med Sci; 2003 Jun; 18(3):319-24. PubMed ID: 12808315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.